HALO (Halozyme) Stock Price

Graphic logo of Halozyme Inc. (HALO)

The Halozyme Therapeutics (HALO) price chart demonstrates the success of a business digitizing the implementation of the ENHANZE system to optimize formula management. Stringent patents and costly testing create a high barrier to entry, pinning the metric at 96.57. Profit growth is driving the adoption of subcutaneous therapy methods, which significantly accelerate recovery and simplify patient care.

Price Chart: Halozyme Therapeutics (HALO) for 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for Halozyme Inc. (HALO)

- stock quotes and analyst forecast:
- business market valuation indicators:
Comprehensive company analysis:HALO Halozyme Inc.
Brand item of Halozyme Therapeutics, Inc.

Analyzing the market price fluctuations of Halozyme Therapeutics (HALO), one can assess the issuer's status within the biotechnology sector. This indicator captures the equilibrium point between supply and demand, determining the asset's current fair value. The price action reflects market expectations regarding the monetization of intellectual property. The absence of manufacturing costs due to the licensing model reduces the volatility of fundamental valuations. This ensures high quote resilience against operational risks.

Who Halozyme Therapeutics competes with

Price Chart BeiGene Oncology (ONC)|RVMD (RevMed) - Price Performance Chart|Stock Price AAPG (Ascentage Pharma Group International)|Price Rate Chart CG Oncology Therapeutics|UroGen Pharma Corp - Stock Price|BCAX - Stock Price|Personalis (PSNL) - Price Chart|ERAS - Market Chart|DCTH (Delcath Corp) - Stock Price|Stock Quotes YmAbs (YMAB)|Stock Price AURA|Stock Price Candel Therapeutics Inc. (CADL)|Price Chart Accuray Inc. ARAY|SLS - Stock Quotes|Actuate Therapeutics Inc - Stock Price|Citius Oncology, Inc (CTOR) - Stock Quotes|HURA: Stock Price|Market Price protaratx.com (TARA)|Price Chart Fate Therapeutics|WHWK: Price Performance Chart|Stock Quotes TCRX (TScan Therapeutics Inc)|CSBR (Champions Oncology, Inc.) - Price Performance Chart|Stock Price XBIT (XBiotech Inc.)|Stock Price CEL-SCI Corporation CVM|OSTX: Stock Quotes|RADX - Stock Price|Artiva (ARTV) - Price Chart|Market Price Adlai Nortye Ltd (ANL)|VERU (Veru Inc) - Stock Price|Market Price Tempest Therapeutics, Inc. TPST|Stock Price XLO|RENB (Renovaro) - Price Performance Chart|Mural Oncology PLC - Stock Quotes|Stock Price Kairos Pharma Inc KAPA|OKUR - Price Chart|CytoMed Therapeutics Limited - Price|CRIS: Stock Price|APLM (Apollomics Corp) - Price Chart|THAR (Tharimmune Corporation) - Stock Price|Share Price ADVB (Advanced Biomed Inc)|Stock Price GNPX|Market Chart Calidi Bio|Price Chart Sunshine Biopharma, Inc. SBFM|XBIO - Stock Quotes|SLRX - Price Chart|PPBT: Price Chart|AONC (AON) - Stock Quotes|BGNE (BeiGene) - Price Chart|Stock Quotes CKPT|ELEV: Price Performance Chart|Stock Price ICAD|Price Chart IKNA (Ikena Oncology Inc.)|Price Chart notablelabs.com NTBL|Price Performance Chart VIRX|MOR - Price Chart|NAYA (NAYA Biosciences Inc.) - Share Price|AAPGV: Stock Price